Company intelligence / Profile preview

InsurTech Holdings

Minneapolis, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

InsurTech Holdings was a U.S. company formed in 2019 to combine Life Epigenetics and YouSurance under a single holding structure focused on applying epigenetic science to the life insurance market. The business used DNA methylation, bioinformatics, and AI-enabled analytics to develop biomarkers of human health and aging for underwriting, consumer engagement, and longevity-related products. In 2020, the company rebranded as FOXO BioScience, and later converted into FOXO Technologies Inc., which became the successor operating business. As a result, InsurTech Holdings is best understood as a historical predecessor entity rather than a currently operating standalone biotech company.

Therapeutic areas: Other
Modalities: BiologicDevice
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on InsurTech Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InsurTech Holdings.

Explore the full profile